Survival rate of Epithelial ovarian cancer in Iran during 2011-2017

Objective: The aim of this study was to determine the 3-year overall survival among the epithelial ovarian cancer patients based on the histology, age, stage of the disease during 2011-2017 in Iran.Methods: This study was a cross sectional retrospective study conducted on 179 newly diagnosed epithelial ovarian cancer patients who had been referred to the Gynecologic Cancers Clinic in a referral training hospital in Tehran during 2011-2017. The patients’ data including the demographic characteristics of the patients and the stage of the disease were analyzed based on the pathologic responses.Results: Among 220 newly diagnosed patients with epithelial ovarian cancer during 2011-2017 who had visited the Gynecologic Cancers Clinic in Tehran (capital of Iran), 179 patients were suitable for follow-up. Among these patients, there were 93 death cases and 85 living cases. The mean age of the patients was 50.5 ± 11.3 years. Most of the patients were at stage 3 (60.9%) and 6.7% of them were at stage 4. The most common pathology was serous adenocarcinoma (70.9%). In this study, the overall survival had no connection with the type of tumor histology (p=0.124), but was related to the stage of the disease (p=0.05). There was no mortality in the stage one and the mucinous adenocarcinoma cases.Discussion: survival in the epithelial ovarian cancer is related to the stage of the disease and among all the pathologies, mucinous adenocarcinoma and clear cell carcinoma has the best survival rate.

کلیدواژه ها:

epithelial ovarian cancer ، survival ، histology subtype ، age